alexa Clusterin: Its Relevance to Antitumour Drug Sensitivity
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Clusterin: Its Relevance to Antitumour Drug Sensitivity

Maximino Redondo*

Department of Biochemistry, Hospital Costa del Sol, University of Málaga, CIBER ESP, Spain

*Corresponding Author:
Dr. Maximino Redondo
Department of Biochemistry
Hospital Costa del Sol
University of Málaga
CIBER ESP, Carretera de Cádiz km 187
29600, Marbella, Málaga, Spain
E-mail: [email protected]

Received Date: September 08, 2011; Accepted Date: September 10, 2011; Published Date: November 12, 2011

Citation: Redondo M (2011) Clusterin: Its Relevance to Antitumour Drug Sensitivity. Clinic Experiment Pharmacol 1:e101. doi: 10.4172/2161-1459.1000e101

Copyright: © 2011 Redondo M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Chemotherapy resistance is a major problem in disease management and the principal factor underlying most cancer deaths. Therefore, a primary goal in cancer research is to develop new ways of inhibiting cancer growth, in part by improving the effectiveness of existing cancer regimens. Resistance to cancer treatment is known to be mediated, at least in part, by the enhanced expression of cell survival proteins that facilitate tumour progression. In this respect, the clusterin protein (CLU) has drawn much attention because of its association with tumorigenesis and progression and its implication in two contrasting functions, survival and apoptosis, which are carry out by two different forms (secretory, s-CLU and nuclear, n-CLU, respectively). Most authors agree that tumour cell survival is related to the overexpression of sCLU and the loss of n-CLU [1]. It is noteworthy that only the cytoplasmic /secretory CLU form (sCLU) and not the nuclear form (nCLU) is expressed in aggressive late stage tumours, which is in line with its anti-apoptotic function. At present, there is no doubt as to the dual forms and functions of CLU.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version